Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test

MADISON, N.J., Jan. 18, 2017 /PRNewswire/ – Quest Diagnostics (DGX), the world’s leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.

» Read Article


Metadata